
21/12/2024
https://www.cff.org/news/2024-12/fda-approves-new-cftr-modulator
Exciting news!! Stay tuned for updates!!
A new CFTR modulator treatment called Alyftrek has been approved for people with CF ages 6 and older who have CFTR mutations that are eligible for Trikafta, as well as 31 other rare mutations that have not been approved previously for any other CFTR modulator.